Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive

Background: Renal tubulointerstitial fibrosis is the pathological hallmark of chronic kidney disease (CKD). Currently, inhibitors of the renin–angiotensin system (RAS) remain the sole therapy in human displaying antifibrotic properties. Further antifibrotic molecules are needed. We have recently rep...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Pharmacol
Hlavní autoři: Huart, Antoine, Klein, Julie, Gonzalez, Julien, Buffin-Meyer, Bénédicte, Neau, Eric, Delage, Christine, Calise, Denis, Ribes, David, Schanstra, Joost P., Bascands, Jean-Loup
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2015
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4313587/
https://ncbi.nlm.nih.gov/pubmed/25698969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2015.00008
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky